Financhill
Sell
39

WLY Quote, Financials, Valuation and Earnings

Last price:
$44.61
Seasonality move :
5.72%
Day range:
$44.58 - $45.08
52-week range:
$30.45 - $53.96
Dividend yield:
3.13%
P/E ratio:
--
P/S ratio:
1.40x
P/B ratio:
3.22x
Volume:
145.9K
Avg. volume:
405.8K
1-year change:
33.98%
Market cap:
$2.4B
Revenue:
$1.9B
EPS (TTM):
-$0.91

Analysts' Opinion

  • Consensus Rating
    John Wiley & Sons has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, John Wiley & Sons has an estimated upside of 29.03% from its current price of $44.95.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $44.95.

Fair Value

  • According to the consensus of 0 analysts, John Wiley & Sons has 29.03% upside to fair value with a price target of -- per share.

WLY vs. S&P 500

  • Over the past 5 trading days, John Wiley & Sons has underperformed the S&P 500 by -4.4% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • John Wiley & Sons does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • John Wiley & Sons revenues have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter John Wiley & Sons reported revenues of $426.6M.

Earnings Growth

  • John Wiley & Sons earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter John Wiley & Sons reported earnings per share of $0.74.
Enterprise value:
3.3B
EV / Invested capital:
1.93x
Price / LTM sales:
1.40x
EV / EBIT:
50.50x
EV / Revenue:
1.88x
PEG ratio (5yr expected):
-0.26x
EV / Free cash flow:
29.95x
Price / Operating cash flow:
22.20x
Enterprise value / EBITDA:
14.24x
Gross Profit (TTM):
$1.3B
Return On Assets:
-1.84%
Net Income Margin (TTM):
-2.82%
Return On Equity:
-6.48%
Return On Invested Capital:
-2.98%
Operating Margin:
15.88%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-10-31 2023-10-31 2024-10-31 2023-10-31 2024-10-31
Income Statement
Revenue $2.1B $2B $1.8B $492.8M $426.6M
Gross Profit $1.4B $1.3B $1.3B $337.2M $319.6M
Operating Income $181.5M $222M $230.5M $71.3M $67.8M
EBITDA $362.6M $112.2M $232.7M $31.1M $100.1M
Diluted EPS $1.75 -$2.09 -$0.91 -$0.35 $0.74
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Balance Sheet
Current Assets $477.3M $500.5M $483M $425.6M $370.3M
Total Assets $3B $3.3B $3.1B $2.8B $2.6B
Current Liabilities $634.7M $644.5M $634.6M $610.3M $561.5M
Total Liabilities $2B $2.2B $2.1B $1.9B $1.9B
Total Equity $1B $1.1B $1.1B $867.3M $755.3M
Total Debt $837.7M $1B $1B $942.6M $961M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-10-31 2023-10-31 2024-10-31 2023-10-31 2024-10-31
Cash Flow Statement
Cash Flow Operations $338.5M $269.8M $197.1M -$1.2M -$5.3M
Cash From Investing -$179.7M -$102M -$99.2M -$26.2M -$20.7M
Cash From Financing -$127.1M -$190.5M -$123.8M $23.9M $11.5M
Free Cash Flow $219.2M $161.6M $110.7M -$27.9M -$23.6M
WLY
Sector
Market Cap
$2.4B
$110M
Price % of 52-Week High
83.3%
66.47%
Dividend Yield
3.13%
0%
Shareholder Yield
4.16%
3.39%
1-Year Price Total Return
33.98%
-16.31%
Beta (5-Year)
0.853
0.704
Dividend yield:
3.13%
Annualized payout:
$1.40
Payout ratio:
-154.35%
Growth streak:
24 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $45.04
200-day SMA
Buy
Level $43.87
Bollinger Bands (100)
Sell
Level 45.22 - 50.68
Chaikin Money Flow
Buy
Level 37.6M
20-day SMA
Sell
Level $47.23
Relative Strength Index (RSI14)
Sell
Level 32.39
ADX Line
Buy
Level 16.01
Williams %R
Neutral
Level -78.8427
50-day SMA
Sell
Level $49.33
MACD (12, 26)
Sell
Level -1.54
25-day Aroon Oscillator
Sell
Level -76
On Balance Volume
Neutral
Level 60.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7666)
Sell
CA Score (Annual)
Level (-1.3177)
Buy
Beneish M-Score (Annual)
Level (-3.5224)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.6122)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

Stock Forecast FAQ

In the current month, WLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The WLY average analyst price target in the past 3 months is --.

  • Where Will John Wiley & Sons Stock Be In 1 Year?

    According to analysts, the consensus estimate is that John Wiley & Sons share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About John Wiley & Sons?

    Analysts are divided on their view about John Wiley & Sons share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that John Wiley & Sons is a Sell and believe this share price will drop from its current level to --.

  • What Is John Wiley & Sons's Price Target?

    The price target for John Wiley & Sons over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is WLY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for John Wiley & Sons is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of WLY?

    You can purchase shares of John Wiley & Sons via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase John Wiley & Sons shares.

  • What Is The John Wiley & Sons Share Price Today?

    John Wiley & Sons was last trading at $44.61 per share. This represents the most recent stock quote for John Wiley & Sons. Yesterday, John Wiley & Sons closed at $44.95 per share.

  • How To Buy John Wiley & Sons Stock Online?

    In order to purchase John Wiley & Sons stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
53
ARQQ alert for Dec 26

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.

Buy
75
SMLR alert for Dec 26

Semler Scientific [SMLR] is down 2.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock